Hemophilia B, a deficiency of coagulation factor IX, leads to spontaneous and trauma-related bleeding, especially in joints and muscles. The landscape of care is rapidly transforming as the Hemophilia B Treatment Market embraces novel therapies and strategic collaborations. Below, we summa